Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 10, Pages 965
Publisher
MDPI AG
Online
2021-09-28
DOI
10.3390/ph14100965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market
- (2020) Caitlyn Norman et al. Drug Testing and Analysis
- From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
- (2020) Tommaso Cassano et al. Frontiers in Pharmacology
- Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
- (2020) Pietro Brunetti et al. Medicina-Lithuania
- Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
- (2020) Arianna Giorgetti et al. Frontiers in Psychiatry
- Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
- (2020) Philipp Klahn Antibiotics-Basel
- The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
- (2020) Vidyasagar Naik Bukke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
- (2020) Torsten Lowin et al. Cell Death & Disease
- High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain
- (2020) Edward T. Wargent et al. PeerJ
- Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
- (2020) Annelies Cannaert et al. ACS Chemical Neuroscience
- Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration
- (2019) José Aguareles et al. Translational Neurodegeneration
- Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature
- (2019) Hayriye Mihrimah Ozturk et al. Cardiovascular Toxicology
- Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice
- (2019) Erica Zamberletti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Δ 8 ‐Tetrahydrocannabivarin has potent anti‐nicotine effects in multiple rodent models of nicotine dependence
- (2019) Zheng‐Xiong Xi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
- (2018) Ran Abuhasira et al. European Journal of Internal Medicine
- The role of cannabinoid signaling in acute and chronic kidney diseases
- (2018) Federica Barutta et al. KIDNEY INTERNATIONAL
- Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
- (2018) Maria Antonietta De Luca et al. CLINICAL THERAPEUTICS
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors
- (2018) Carolina Noble et al. Drug Testing and Analysis
- Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices
- (2018) Silvia Graziano et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- THC and gabapentin interactions in a mouse neuropathic pain model
- (2018) Nicholas Atwal et al. NEUROPHARMACOLOGY
- Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study
- (2017) Sabrina Giacoppo et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- Synthetic cannabinoids in the kidneys
- (2017) Alper Alp et al. Revista da Associacao Medica Brasileira
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
- (2017) Arianna Bettiga et al. Scientific Reports
- Cannabinoid Hyperemesis Syndrome
- (2016) J. Andrew Woods et al. AMERICAN JOURNAL OF THERAPEUTICS
- Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
- (2016) Sonia Hernández-Tiedra et al. Autophagy
- Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
- (2016) Sindiswa T. Lukhele et al. BMC Complementary and Alternative Medicine
- The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
- (2016) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- The CB2 receptor and its role as a regulator of inflammation
- (2016) Caroline Turcotte et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Antitumorigenic targets of cannabinoids – current status and implications
- (2016) Robert Ramer et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabinoid derivatives exert a potent anti-myeloma activity bothin vitroandin vivo
- (2016) M. Victoria Barbado et al. INTERNATIONAL JOURNAL OF CANCER
- Repeated Thrombosis After Synthetic Cannabinoid Use
- (2016) Amer Raheemullah et al. JOURNAL OF EMERGENCY MEDICINE
- Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage
- (2016) Kavelin Rumalla et al. Journal of Stroke & Cerebrovascular Diseases
- Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
- (2016) A. Ortega et al. LIFE SCIENCES
- Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
- (2016) Aviva Breuer et al. PLoS One
- Modulation of cellular redox homeostasis by the endocannabinoid system
- (2016) Christopher Lipina et al. Open Biology
- Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage
- (2016) Kavelin Rumalla et al. Journal of Stroke & Cerebrovascular Diseases
- Synthetic Cannabinoids
- (2015) Brooke Mills et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication
- (2015) Eran Lavi et al. EUROPEAN JOURNAL OF PEDIATRICS
- In vivo detection of the new psychoactive substance AM-694 and its metabolites
- (2015) Elisabetta Bertol et al. FORENSIC SCIENCE INTERNATIONAL
- Devastating Delayed Leukoencephalopathy Associated with Bath Salt Inhalation
- (2015) C. L. Kramer et al. Neurocritical Care
- Cannabinoids: structures, effects, and classification
- (2015) V. A. Shevyrin et al. RUSSIAN CHEMICAL BULLETIN
- Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid
- (2015) Mert Mahsuni Sevinc WORLD JOURNAL OF GASTROENTEROLOGY
- Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke
- (2015) Valérie Wolff et al. Biomed Research International
- Severe Illness Associated with Reported Use of Synthetic Cannabinoids — Mississippi, April 2015
- (2015) Amelia M. Kasper et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- MAM-2201 (Analytically Confirmed) Intoxication After “Synthacaine” Consumption
- (2014) Davide Lonati et al. ANNALS OF EMERGENCY MEDICINE
- Acute kidney injury associated with smoking synthetic cannabinoid
- (2014) G. L. Buser et al. CLINICAL TOXICOLOGY
- A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid
- (2014) M. Takematsu et al. CLINICAL TOXICOLOGY
- Phytocannabinoids and epilepsy
- (2014) R. G. dos Santos et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
- (2014) M. H. Baumann et al. JOURNAL OF NEUROSCIENCE
- Synthetic Cannabinoid Leading to Cannabinoid Hyperemesis Syndrome
- (2014) Benjamin L. Bick et al. MAYO CLINIC PROCEEDINGS
- Long-Term Effects of Cannabis on Brain Structure
- (2014) Giovanni Battistella et al. NEUROPSYCHOPHARMACOLOGY
- Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
- (2014) Sara Valdeolivas et al. Neurotherapeutics
- Smoking Synthetic Marijuana Leads to Self-Mutilation Requiring Bilateral Amputations
- (2014) Karim A. Meijer et al. ORTHOPEDICS
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1receptor-independent mechanism
- (2013) T D M Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds
- (2013) Kathryn A. Seely et al. FORENSIC SCIENCE INTERNATIONAL
- Toxicological Findings of Synthetic Cannabinoids in Recreational Users
- (2013) R. Kronstrand et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Ischemic stroke after use of the synthetic marijuana "spice"
- (2013) M. J. Freeman et al. NEUROLOGY
- Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice
- (2012) Carol A. Paronis et al. BEHAVIOURAL PHARMACOLOGY
- Effect of long-term cannabis use on axonal fibre connectivity
- (2012) A. Zalesky et al. BRAIN
- AKI Associated with Synthetic Cannabinoids: A Case Series
- (2012) G. K. Bhanushali et al. Clinical Journal of the American Society of Nephrology
- First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201
- (2012) David McQuade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Synthetic Cannabis and Respiratory Depression
- (2012) Felecia N. Jinwala et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Synthetic Cannabinoid Intoxication: A Case Series and Review
- (2012) Carson R. Harris et al. JOURNAL OF EMERGENCY MEDICINE
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Cannabinoid Hyperemesis: A Case Series of 98 Patients
- (2012) Douglas A. Simonetto et al. MAYO CLINIC PROCEEDINGS
- COX-2 and PPAR- Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
- (2012) R. Ramer et al. MOLECULAR CANCER THERAPEUTICS
- Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
- (2012) Eva de Lago et al. NEUROPHARMACOLOGY
- Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
- (2012) Kathryn A. Seely et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells
- (2012) Nazila Pourkhalili et al. TOXICOLOGY MECHANISMS AND METHODS
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
- (2012) M Mecha et al. Cell Death & Disease
- Prospects for cannabinoid therapies in basal ganglia disorders
- (2011) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy
- (2011) Kayte A. Jenkin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
- (2011) E L Karschner et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Severe Toxicity Following Synthetic Cannabinoid Ingestion
- (2011) J. Lapoint et al. CLINICAL TOXICOLOGY
- Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
- (2011) F. Barutta et al. DIABETES
- Synthetic cannabinoid JWH-018 and psychosis: An explorative study
- (2011) Susanna Every-Palmer DRUG AND ALCOHOL DEPENDENCE
- A survey study to characterize use of Spice products (synthetic cannabinoids)
- (2011) Ryan Vandrey et al. DRUG AND ALCOHOL DEPENDENCE
- Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers.
- (2011) Staci A. Gruber et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinsons Disease
- (2011) J. P. Little et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?
- (2011) K. A. Seely et al. MOLECULAR INTERVENTIONS
- Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making
- (2011) Jatin G Vaidya et al. NEUROPSYCHOPHARMACOLOGY
- Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm
- (2011) Andrés Uribe-Mariño et al. NEUROPSYCHOPHARMACOLOGY
- Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
- (2011) A. Mir et al. PEDIATRICS
- Beyond THC: The New Generation of Cannabinoid Designer Drugs
- (2011) Liana Fattore et al. Frontiers in Behavioral Neuroscience
- How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study
- (2010) PAUL GRIFFITHS et al. ADDICTION
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- (2010) Sean D. McAllister et al. BREAST CANCER RESEARCH AND TREATMENT
- CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
- (2010) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
- (2010) F. Barutta et al. DIABETES
- Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
- (2010) Andrew J. Hill et al. EPILEPSIA
- The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells
- (2010) Paraskeva INTERNATIONAL JOURNAL OF ONCOLOGY
- Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells
- (2010) J.C. Lim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds
- (2010) Sebastian Dresen et al. JOURNAL OF MASS SPECTROMETRY
- Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation
- (2010) D. A. Patterson et al. Journal of the American Board of Family Medicine
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
- (2010) Abir T. El-Alfy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
- (2010) Matthijs G. Bossong et al. PROGRESS IN NEUROBIOLOGY
- Spice drugs as a new trend: Mode of action, identification and legislation
- (2010) I. Vardakou et al. TOXICOLOGY LETTERS
- Investigating a not-so-natural high
- (2009) Christine Piggee ANALYTICAL CHEMISTRY
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product
- (2009) Nahoko Uchiyama et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors
- (2009) Guilherme B.L. De Freitas et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Spice: A never ending story?
- (2009) Rainer Lindigkeit et al. FORENSIC SCIENCE INTERNATIONAL
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
- (2009) Volker Auwärter et al. JOURNAL OF MASS SPECTROMETRY
- Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions
- (2009) Luca Ferraro et al. JOURNAL OF NEURAL TRANSMISSION
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Δ9-THC
- (2009) Pasqualina Castaldo et al. PHARMACOLOGICAL RESEARCH
- Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
- (2009) J. Z. Long et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)
- (2008) Michelle L. Holland et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry
- (2008) M DELMARRAMIREZFERNANDEZ et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2
- (2008) M.G. Morgese et al. NEUROCHEMISTRY INTERNATIONAL
- Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism
- (2008) Kazuhide Hayakawa et al. NEUROPHARMACOLOGY
- Δ9-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons
- (2008) K. Sano et al. NEUROSCIENCE
- Secondary metabolism in cannabis
- (2008) Isvett Josefina Flores-Sanchez et al. PHYTOCHEMISTRY REVIEWS
- Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats
- (2008) Viviana Trezza et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started